| Literature DB >> 23108393 |
R Amato1, D Scumaci, L D'Antona, R Iuliano, M Menniti, M Di Sanzo, M C Faniello, E Colao, P Malatesta, A Zingone, V Agosti, F S Costanzo, A M Mileo, M G Paggi, F Lang, G Cuda, P Lavia, N Perrotti.
Abstract
The serum- and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is involved in the transduction of growth factor-dependent cell survival and proliferation signals. Growing evidence now points to Sgk1 as a key element in the development and/or progression of human cancer. To gain insight into the mechanisms through which Sgk1 regulates cell proliferation, we adopted a proteomic approach to identify up- or downregulated proteins after Sgk1-specific RNA silencing. Among several proteins, the abundance of which was found to be up- or downregulated upon Sgk1 silencing, we focused our attention of RAN-binding protein 1 (RANBP1), a major effector of the GTPase RAN. We report that Sgk1-dependent regulation of RANBP1 has functional consequences on both mitotic microtubule activity and taxol sensitivity of cancer cells.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23108393 DOI: 10.1038/onc.2012.470
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867